Root Financial Partners
STLN icon

Root Financial Partners’s Starling Oncology STLN Stock Holding History

Root Financial Partners’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$322 Buy
+51
New +$305 ﹤0.01% 3380
2026
Q2 		– Sell
-51
Closed -$157 – 2942
2026
Q1 		$157 Buy
+51
New +$156 ﹤0.01% 3200

Other funds holding STLN

Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Kingswood Wealth Advisors
Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Berkshire Money Management
Berkshire Money Management Dalton, Massachusetts $1.16B AUM 13.8% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Root Financial Partners's STLN Position: Q3 2026 in Review

Root Financial Partners opened a new position in Starling Oncology (STLN) in Q3 2026: 51 shares worth $322. The stake represents ﹤0.01% of the portfolio and ranks #3380 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in STLN as recently as Q1 2026.

Root Financial Partners first reported a position in STLN in Q1 2026 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • Root Financial Partners held 51 shares of Starling Oncology worth $322 as of Q3 2026.
  • Starling Oncology was a new Root Financial Partners position in Q3 2026.
  • Starling Oncology made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3380 holding.
  • Root Financial Partners first reported a position in Starling Oncology in Q1 2026 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.